Quantcast
Close Window
   
Welcome :o)
Welcome to another year exposing the harms of Johnson & Johnson products and the executives that care more about money than human health...
 
There really is a highly effective way to put an end to mass tort lawsuits: GET JOHNSON & JOHNSON AND SUBSIDIARY KNOWN DEFECTIVE, HARMFUL AND/OR TOXIC PRODUCTS OFF THE GLOBAL MARKET
 
This work is 100% independent. I am NOT a victim, NOT a lawyer, NOT paid by anyone other than visitors to the site. And no, I do not own any stock in Johnson & Johnson.
 
Emily.
HomeAbout

Content List
100+ articles of harm and corruption by Johnson & Johnson and subsidiary products.
Click for content list...

Glad to see you :o)
Latest Content: April 8, 2017...
2017 Johnson and Johnson US Lawsuit Update: Jump from 76,400 to 104,700 (2017, April 8)
Yet another year of a dramatic increase in lawsuits against Johnson & Johnson and subsidiaries in a lot of countries over a variety of products, and don't include many products with legal action pending.
levaquin, risperdal, asr, transvaginal, tvt, mesh, lawsuit, investor
 
March 2017 marked FIVE YEARS of work exposing harm, corruption and massive costs of flood of KNOWN HARMFUL Johnson & Johnson products.
 
NOTICE: DUE TO HOMELESSNESS, I DO NOT HAVE ANY MONEY TO PUT TOWARDS THIS PROJECT.
 
Site saved again by a woman in the United Kingdom. Thank you VERY much!
 
This web site currently has the attention of:
click link to validate IP address through whatismyipaddress.com
 
US GOVERNMENT:
US Senate
US Department of Defense
US Department of Justice
US Homeland Security
 
GLOBAL FINANCIAL INSTITUTIONS:
...including many Johnson & Johnson shareholders ;o)
 
Vanguard
The Bank of New York Mellon Corp
Lloyds Banking Group PLC
Royal Bank of Canada
Bank of America
Harris Trust & Savings Bank
Deutsche Bank
Macquarie Bank
PNC Bank
Crédit Agricole Bank
Royal Bank of Scotland
Raymond James Financial
BlackRock Financial Management
...and many, many more from all over the world ;o)
 
I am not paid by lawyers, doctors, etc - ONLY by visitors to the web site, the PEOPLE I am working for, PEOPLE like you. Currently reduced to only a part-time job, I donate the remainder of my time to take care of all the work involved in maintaining the site by doing the research, search engine optimized content, responding to victim emails and social media to create awareness among consumers to prevent new injuries as well as continue increasing awareness among Johnson & Johnson shareholders and global health organizations. Feel free to browse list of notable visitors to the web site.
 
So far April raised a TOTAL of:
$50 April 1 from US
$50 April 11 from UK
$100 TOTAL (it's not a wonder I'm starving on the streets of homeless hell, eh?)
 
God Bless You and Yours and keep you safe from harm,
Emily
 
Please send financial support to keep this very important GLOBAL consumer safety effort going...
 
Enter any amount in GiftBox below or PayPal to Email:
 
emily@johnsonandtoxin.com
 
$.00   
 
Sponsored in part by...
Examining Medicine An in-depth comprehensive, frequently updated look at extreme risks and permanent brain damage caused by psychiatric drugs.
----- / / -----
Fiddaman Blog Bob Fiddaman has been writing about the dangers of antidepressants since 2006. In 2011 he was presented with two human rights awards from the Citizens Commission on Human Rights.
----- / / -----
Special Needs Advocate Power Join me as we work hard to ensure what our very special children need.

Governments Throw Taxpayer Money at Johnson & Johnson for Ebola Development WHY? JNJ has $30 billion in cash assets!
Here we go again - more of our tax dollars thrown at a company that is already ripping us off.

Keywords: corporate, governance, government, handout, welfare, healthcare, taxes, subsidy
Date Created/Edited: 2015, January 25
 

Special Sections....
 
Mesh Files
Baby Powder (talc) Files
Risperdal Files
Levaquin Files
Xarelto Files
Hips Files
Letters to Shareholders
SEC Lawsuits Files

 
Recent Content....
Why President Trump Should Shut Down US FDA (2017, March 28)
Healthcare organizations around the world depend on US FDA decisions, however, profit, rather than safety, seems to be the primary motivation.
healthcare, health, obamacare, donald, trump, fda, fraud, kickback
 
The Fastest Growing Segment of Johnson & Johnson Is... (2016, November 15)
Growing over 29% in 2016, this is definitely the fastest growing segment of Johnson & Johnson!
johnson & johnson, J&J, JNJ, 2016, lawsuit, lawsuits, tort, liability
 
Third Quarter 2016 Lawsuits Against Johnson & Johnson Still Exploding! Now 99,000! (2016, November 15)
Growing every quarter, lawsuits against Johnson & Johnson in United States alone are now well over 99,000.
talc, risperdal, asr, hip, baby powder, tvt, mesh, lawsuit
 
The Difference Between Guinea Pig and Cash Cow (2016, September 27)
People keep saying pharma is using us as 'guinea pigs'. Uh, not quite. Take a minute to learn the difference between a 'guinea pig' and a 'cash cow'.
guinea pig, immunization, vaccination, profit, harm, autism, disability, asthma
 
Johnson & Johnson Victims at Risk of RE-Victimization (2016, August 22)
If you are currently a victim of a known harmful Johnson & Johnson subsidiary product and have high medical needs due to your injuries, you are at increased risk of becoming a victim of another known harmful Johnson & Johnson subsidiary product.
jnj, johnson and johnson, johnson & johnson, victim, mesh, hip, levaquin, risperdal
 
Wealthy Most at Risk for Harm by Johnson & Johnson and Subsidiary Products (2016, August 22)
If you make over $100,000 a year, you are far more likely than lower incomes to become a victim of a Johnson & Johnson and/or subsidiary product.
healthcare, cost, co-pay, risk, deductable, insurance, victim, salary
 
Second Quarter 2016 Lawsuits Against Johnson & Johnson Leap Again From 82,200 to 90,700 (2016, August 4)
Growing every quarter, lawsuits against Johnson & Johnson in United States alone are now well over 90,700.
talc, risperdal, asr, hip, baby powder, tvt, mesh, lawsuit
 
Johnson & Johnson Animas Defective Diabetes Devices (2016, August 4)
Gosh and golly gee willikers, yet another Johnson & Johnson subsidiary, Animas, totally sucks, jah?
Johnson and Johnson, Johnson & Johnson, animas, vibe, diabetes, insulin, device, pump
 
Johnson & Johnson Ethicrap, I Mean EthiCON, More JNJ JUNK (2016, July 25)
As I've mentioned, Johnson & Johnson has so many bad products I have to put a bunch in each article now to try to keep up. Now for EthiCON crap.
Johnson and Johnson, Johnson & Johnson, ethicon, harmonic ace, morcellator, physiomesh, secure strap, stapler
 
Johnson and Johnson Janssen Xarelto Slaughter (2016, July 8)
Overstating benefits, downplaying (or not disclosing) risks. Xarelto by Johnson and Johnson Janssen killing people left and right. Over 500 DEAD, 7,100 lawsuits already. Lovely, eh?
false, marketing, death, dead, xarelto, FDA, lawsuit, Janssen
 
This Convinced THREE Juries That Johnson and Johnson Talc Increases Ovarian Cancer (2016, May 14)
One very simple fact convinced THREE juries that Johnson & Johnson talc increases risk of developing ovarian cancer.
Johnson and Johnson, Johnson & Johnson, baby, powder, cancer, lawsuit, ovarian, talc
 
This is absurd:
Johnson & Johnson : gets £100m from Europe's IMI to accelerate Ebola vaccine development
 
Crucell, a subsidiary of Janssen which is a subsidiary of Johnson & Johnson, was given $8 million for fiscal year 2014 by United States National Institutes of Health for 'Research and Development'.
 
Hey, wait, I keep seeing that Johnson & Johnson CEO Alex Gorsky claims the high costs of drugs is related to the high cost of development. Um, looks like our tax dollars are covering the development part so what, exactly, is Gorsky talking about?
 
Oh, likely exercising that exclusive Johnson & Johnson Constituational Right to Lie, or at least be deceptive. Yes, research and development does cost a lot of money. Totally agreed. But that's not what is driving up the cost of drugs since research and development is mostly paid for by taxpayers and individuals. In addition to raping the public health system for development money, tons of money is constantly pouring in from thousands of disease awareness groups such as breast cancer, asthma, arthritis, and so on.
 

 

As of September, 2014, Johnson & Johnson had in excess of $33 BILLION in cash and short-term investments. Does anyone else think there is something wrong with giving hundreds of millions of taxpayer dollars to a corporation with more than $33 BILLION while taxpayers are struggling to pay their mortgages and fuel bills? The high cost of healthcare is simple: Greed.
 
This isn't 'Corporate Welfare' or 'Subsidy' - this is blatant, out of control greed. However, as more Americans lose their homes to foreclosure and everything else in bankruptcy due to the high cost of healthcare eating up an ever-increasing portion of their paycheck they can no longer pay on bank debts, the banks will continue to sink since the loss of revenue from consumer bankruptcies and foreclosures will likely outpace the revenue gained in dividends from healthcare companies such as Johnson & Johnson.
 
Gee, wonder what's going to happen when investment bank executives realize the bleeding hole of bankruptcies and foreclosures are caused by corruption causing the astronomical rise in healthcare costs?
 
Resources:
1. Author (2015, January 19). Johnson & Johnson : gets €100m from Europe's IMI to accelerate Ebola vaccine development Publication. Retrieved from http://www.4-traders.com/JOHNSON--JOHNSON-4832/news/Johnson--Johnson--gets-A100m-from-Europes-IMI-to-accelerate-Ebola-vaccine-development-19731075/
 
2. United States National Institutes of Health (2014). Crucell Award 2014 US NIH Grant Awards. Retrieved from http://report.nih.gov/award/index.cfm?ot=&fy=2014&state=&ic=&fm=&orgid=10001490&distr=&rfa=&om=n&pid=#tab2
 
3. Emily Patterson (Content list, frequently updated). The Other Side of JNJ CEO Alex Gorsky Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/gorsky.shtml
 
4. Emily Patterson (2013, June 20). Johnson & Johnson Defense Against $1.2 Billion Arkansas Risperdal: We Have a Constitutional Right to Lie Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/right_to_lie.shtml
 
5. Yahoo (014, September). Johnson & Johnson Cash and Short Term Investments (Quarterly) Chart Y-Charts. Retrieved from http://ycharts.com/companies/JNJ/cash_on_hand
 
6. Emily Patterson (2012, October 27). Rising Health Care Costs Fueling 50% of Foreclosures and Economic Crisis Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/healthcare_foreclosures.shtml
 
7. Emily Patterson (2012, October 27). Content Title Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/healthcare_bankruptcies.shtml
 
8. David Futrelle (2012, March 23). Will the Cost of Health Insurance Eventually Eat Up Your Entire Paycheck? Study Says Yes. TIME Business. Retrieved from http://business.time.com/2012/03/23/will-the-cost-of-health-insurance-eventually-eat-up-your-entire-paycheck-study-says-yes/
 
 
 
 
 
 
 
All contents Copyright © 2012-2016 Emily Patterson / Johnson and Toxin. All rights reserved.
 
Web Site and Admin Info:
Home
About
Contact
Disclaimers
Privacy Policy
Site Statistics
Site Resources
Financial Disclosure

 
Recently Posted:
2015 Johnson & Johnson US Lawsuit Update: Jump from 48,500 to 56.500
 
Johnson & Johnson Plans to Expand Healthcare Cost Crisis and Product Liability in Asia
 
Who REALLY Pays for Drug Development? US TAXPAYERS - $21 BILLION for fiscal year 2014
 
Johnson & Johnson Janssen Xarelto Marketed In Violation of FDA Regulations
 
Johnson & Johnson Destroys Thousands of Files Related to Vaginal Mesh
 
Johnson & Johnson: The Global Lawsuit Company


 
 
Most Popular:
The Ever-Growing Number of Lawsuits Against Johnson & Johnson
 
Johnson & Johnson Credo Analysis
 
Johnson & Johnson $4 Billion for DePuy Hip Harm in U.S., With Lawsuits in at Least 4 More Countries